Gabapentinhas undergone investigation for treating hot flashes, after patients taking it for other indications incidentally noted improvement of hot flashes. Although it is an analogue of gamma-aminobutyric acid (GABA) and is used to treat neurologic disorders such as seizures and neuropathic pain, gabapentin does not affect A 2005 study by Pandya et al. randomized 420 women with breast cancer and experiencing at least 2 hot flashes in 24 hours to one of three groups: gabapentin 300 mg daily, gabapentin 900 mg daily, or placebo 23. After 8 weeks, the 300 mg dose group showed a modest 20% reduction in hot flashes, but the 900 mg dose group showed a reduction of In a recently published clinical trial in men with prostate cancer who were treated with GnRH analogues and antiandrogens, the disabling hot flashes were successfully treated with gabapentin. 32 Unfortunately, gabapentin has been associated with anorgasmy in both men and women. 33 Nonetheless, a thorough study of gabapentin in rigorous clinical Evidence from several randomized controlled trials supports the effectiveness of oxybutynin in treating hot flashes, showing reduction in hot flash frequency by up to 70% to 86%. Oxybutynin is an effective treatment for overactive bladder symptoms, which can increase in hypoestrogenic states. Fortunately, a new treatment option may be able to treat hot flashes without the risk. Gabapentin, an anticonvulsant, may be effective for the treatment of hot flashes. Often sold as Neurontin, gabapentin is approved by the Food and Drug Administration (FDA) for the treatment of epilepsy. Although the studies were few, all showed gabapentin to be safe and effective in the treatment of hot flashes. At doses used to control hot flashes, gabapentin was well tolerated, with drowsiness as its most reported adverse effect. Gabapentin can be considered effective in the treatment of hot flashes and should be considered a reasonable Based on the anecdotal information, the current phase 2 clinical trial was developed to more definitively evaluate gabapentin's efficacy against hot flashes and its associated toxicity. Gabapentin appears to be effective for reducing hot flashes, although potentially not as effective as estrogen therapy. A 2019 review and meta-analysis in the American Journal of Obstetrics Current non-pharmacologic treatments for hot flashes include life-style changes such as weight loss, smoking cessation, and wearing light clothing in layers. The most effective treatment option for hot flashes is estrogen therapy, which was the standard therapy for more than 60 years. Black cohosh may be effective for short-term treatment of hot flashes. 45 percent decrease in hot flashes with gabapentin versus 29 percent with placebo (P = .02, NNT = 6) Somnolence; dizziness: Gabapentin presents a promising option for managing hot flashes, particularly for those who haven’t found relief through other treatments. By understanding its benefits, potential side effects, and proper administration, you can make informed decisions about its use. Gabapentin (Neurontin, Gralise, others). This antiseizure medicine helps ease hot flashes. Side effects can include being drowsy, dizzy or tired and swelling in the arms and legs, called edema. Pregabalin (Lyrica). This is another anti-seizure medicine that can help ease hot flashes. The following search terms were used: "menopause," "hot flushes," "vasomotor symptoms," "gabapentin," and "non-hormonal therapy." Primary outcomes were frequency, duration, and composite score of hot flushes. Secondary outcomes were adverse effects and dropout rate. Menopausal hormone therapy is the most effective tool for treating hot flashes and night sweats associated with menopause. It also can help to prevent osteoporosis. "This new medication shouldn't replace hormone therapy," says Dr. Kling. "Hormone therapy remains the most effective treatment for hot flashes and night sweats. earched the PubMed, MEDLINE, EMBASE, and CENTRAL databases for English-language articles published until June, 2018. The following search terms were used: “menopause,” “hot flushes,” “vasomotor symptoms,” “gabapentin,” and “non-hormonal therapy.” Primary outcomes were frequency, duration, and composite score of hot flushes. Secondary outcomes were adverse effects and This review investigated the efficacy and tolerability of gabapentin for the treatment of hot flashes in menopausal women. Gabapentin was associated with reductions in the severity and frequency of hot flashes in menopausal women, but there was substantial variation in the results across the included trials. The authors' conclusions appear to be reliable based on the evidence presented.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |